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Autophagy is a catabolic pathway conserved among eukaryotes that allows cells to rapidly eliminate large unwanted structures
such as aberrant protein aggregates, superﬂuous or damaged organelles, and invading pathogens. The hallmark of this transport
pathway is the sequestration of the cargoes that have to be degraded in the lysosomes by double-membrane vesicles called
autophagosomes. The key actors mediating the biogenesis of these carriers are the autophagy-related genes (ATGs). For a long
time, it was assumed that autophagy is a bulk process. Recent studies, however, have highlighted the capacity of this pathway to
exclusively eliminate speciﬁc structures and thus better fulﬁl the catabolic necessities of the cell. We are just starting to unveil the
regulation and mechanism of these selective types of autophagy, but what it is already clearly emerging is that structures targeted
to destruction are accurately enwrapped by autophagosomes through the action of speciﬁc receptors and adaptors. In this paper,
we will brieﬂy discuss the impact that the selective types of autophagy have had on our understanding of autophagy.
1.Introduction
Three diﬀerent pathways can deliver cytoplasmic com-
ponents into the lumen of the lysosome for degrada-
tion. They are commonly referred to as autophagy (cell
“self-eating”) and include chaperone-mediated autophagy
(CMA), microautophagy, and macroautophagy. CMA in-
volves the direct translocation of speciﬁc proteins contain-
ing the KFERQ pentapeptide sequence across the lysosome
membrane[1,2].Microautophagy,ontheotherhand,entails
the invagination and pinching oﬀ of the lysosomal limiting
membrane, which allows the sequestration and elimination
of cytoplasmic components. The molecular mechanism
underlying this pathway remains largely unknown. The only
cellular function that so far has been indisputably assigned
to microautophagy is the turnover of peroxisomes under
speciﬁcconditionsinfungi[3].Recently,ithasbeenreported
the existence of a microautophagy-like process at the late
endosomes, where proteins are selectively incorporated into
the vesicles that bud inward at the limiting membrane of
these organelles during the multivesicular bodies biogenesis
[4]. In contrast to CMA and microautophagy, macroau-
tophagy (hereafter referred to as autophagy) entails the
formation of a new organelle, the autophagosome, which
allows the delivery of a large number of diﬀerent cargo
molecules into the lysosome.
Autophagy is a primordial and highly conserved intra-
cellular process that occurs in most eukaryotic cells and par-
ticipates in stress management. This pathway involves the de
novoformationofvesiclescalledautophagosomes,whichcan
engulf entire regions of the cytoplasm, individual organelles,
protein aggregates, and invading pathogens (Figure 1). The
autophagosomes fuse with endosomal compartments to
form amphisomes prior to fusion with the lysosome, where
their contents are degraded and the resulting metabolites are
recycled back to the cytoplasm (Figure 1). Unique features
of the pathway include the double-membrane structure of
the autophagosomes, which were originally characterized
over 50 years ago from detailed electron microscopy studies
[5]. Starting in the 1990s yeast mutational studies began
the genetic and molecular characterization of the key com-
ponents required to initiate and build an autophagosome2 International Journal of Cell Biology
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Figure 1: Multiple Atg proteins govern autophagosome formation. In response to inactivation of mTORC1 (but also other cellular and
environmental cues), the ULK1 complex is activated and translocates in proximity of the endoplasmic reticulum (ER). Thereafter, the ULK1
complexregulates theclass IIIPI3Kcomplex. Atg9L,amultimembranespanningprotein,isalsoinvolved in an earlystageofautophagosome
formation by probably supplying part of the membranes necessary for the formation and/or expansion. Local formation of PI3P at sites
called omegasomes promotes the formation of the phagophore, from which autophagosomes appear to be generated. The PI3P-binding
WIPI proteins (yeast Atg18 homolog), as well as the Atg12-Atg5-Atg16L1 complex and the LC3-phosphatidylethanolamine (PE) conjugate
play important roles in the elongation and closure of the isolation membrane. Finally, the complete autophagosome fuses with endosomes
or endosome-derived vesicles forming the amphisome, which subsequently fuses with lysosomes to form autolysosomes. In the lysosomes,
the cytoplasmic materials engulfed by the autophagosomes are degraded by resident hydrolases. The resulting amino acids and other basic
cellular constituents are reused by the cell; when in high levels they also reactivate mTORC1 and then suppress autophagy.
[6]. Subsequently, genetic and transgenic studies in plants,
worms, fruit ﬂies, mice, and humans have underscored the
pathway’sconservationandhavebeguntounveiltheintricate
vital role that autophagy plays in the physiology of cells and
multicellular organisms.
For a long time, autophagy was considered a non-
selective pathway induced as a survival mechanism in
response to cellular stresses. Over the past several years,
however, it has become increasingly evident that autophagy
also is a highly selective process involved in clearance of
excess or dysfunctional organelles, protein aggregates and
intracellular pathogens. In this introductory piece, we will
brieﬂy discuss the molecular mechanisms of selective types
of autophagy and their emerging importance as a quality
control to maintain cellular and organismal health, aspects
that will be presented in deep in the reviews of this
special issue of the International Journal of Cell Biology and
highlighted by the research papers.
2. The Mechanismof Autophagy
2.1. The Function of the Atg Proteins. Autophagosomes are
formed by expansion and sealing of a small cistern known
as the phagophore or isolation membrane (Figure 1). Once
complete, they deliver their cargo into the hydrolytic lumen
of lysosomes for degradation. A diverse set of componentsInternational Journal of Cell Biology 3
are involved in the biogenesis of autophagosomes, which
primarily includes the proteins encoded by the autophagy-
related genes (ATG). Most ATG genes have initially been
identiﬁed and characterized in yeast. Subsequent studies
in higher eukaryotes have revealed that these key factors
are highly conserved. To date, 36 Atg proteins have been
identiﬁed and 16 are part of the core Atg machinery essential
for all autophagy-related pathways [7]. Upon autophagy
induction, these proteins associate following a hierarchical
order [8, 9] to ﬁrst mediate the formation of the phagophore
and then to expand it into an autophagosome [10, 11].
While their molecular functions and their precise contri-
bution during the biogenesis of double-membrane vesicles
remain largely unknown, they have been classiﬁed in 4
functional groups of genes: (1) the Atg1/ULK complex, (2)
the phosphatidylinositol 3-kinase (PI3K) complex, (3) the
Atg9 traﬃcking system, and (4) the two parallel ubiquitin-
like conjugation systems (Figure 1).
The Atg1/ULK complex consists of Atg1, Atg13, and
Atg17 in yeast, and ULK1/2, Atg13, FIP200 and Atg101 in
mammals [12–15]. This complex is central in mediating the
induction of autophagosome biogenesis and as a result it is
the terminal target of various signaling cascades regulating
autophagy, such as the TOR, insulin, PKA, and AMPK
pathways [16]( Figure 1). Increased activity of the Atg1/ULK
kinase is the primary event that determines the acute induc-
tion and upregulation of autophagy. It is important to note
thatULK1ispartofaproteinfamilyandtwoothermembers,
ULK2 and ULK3, have been shown play a role in autophagy
induction as well [14, 17]. The expansion of this gene family
may reﬂect the complex regulation and requirements of the
pathway in multicellular long-lived organisms. Stimulation
of the ULK kinases is achieved through an intricate network
of phosphorylation and dephosphorylation modiﬁcations
of the various subunits of the Atg1/ULK complex. For
example, Atg13 is directly phosphorylated by TOR and the
phosphorylationstateofAtg13modulatesitsbindingtoAtg1
and Atg17. Inactivation of TOR leads to a rapid dephos-
phorylation of Atg13, which increases Atg1–Atg13–Atg17
complex formation, stimulates the Atg1 kinase activity and
induces autophagy [18, 19]. The mAtg13 is also essential for
autophagy, but seems to directly interact with ULK1, ULK2
and FIP200 independently of its phosphorylation state [13,
14]. In addition, there are several phosphorylation events
within this complex as well, including phosphorylation of
mAtg13 by ULK1, ULK2, and TOR; phosphorylation of
FIP200 by ULK1 and ULK2; phosphorylation of ULK1 and
ULK2 by TOR [13, 14]. Additional studies are required
to fully characterize the functional signiﬁcance of these
posttranslational modiﬁcations.
Autophagy is also regulated by the activity of PI3K
complexes. Yeast contains a single PI3K, Vps34, which is
present in two diﬀerent tetrameric complexes that share
3 common subunits, Vps34, Vps15, and Atg6 [20]. Com-
plex I is required for the induction of autophagy and
through its fourth component, Atg14, associates to the
autophagosomal membranes where the lipid kinase activity
of Vps34 is essential for generating the phosphatidylinositol-
3-phosphate(PI3P)thatpermitstherecruitmentofotherAtg
proteins [9, 21]( Figure 1). Complex II contains Vps38 as the
fourth subunit and it is involved in endosomal traﬃcking
and vacuole biogenesis [20]. There are three types of PI3K in
mammals: class I, II, and III. The functions of class II PI3K
remains largely unknown, but both classes I and III PI3Ks
are involved in autophagy. While class I PI3K is principally
implicated in the modulation of signalling cascades, class III
PI3K complexes regulate organelle biogenesis and, like yeast,
contain three common components: hVps34, p150 (Vps15
ortholog), and Beclin 1 (Atg6 ortholog). The counterparts
of Atg14 and Vps38 are called Atg14L/Barkor and UVRAG,
respectively[22–24].TheAtg14L-containingcomplexplaysa
central role in autophagy and functions very similarly as the
yeast complex I by directing the class III PI3K complex I to
the phagophore to produce PI3P and initiate the recruitment
of the Atg machinery (Figure 1). Atg14L is thought to
be present on the ER irrespective of autophagy induction
[25]. Upon starvation, Atg14L localizes to autophagosomal
membranes [8]. Importantly, depletion of Atg14L reduces
PI3P production, impairs the formation of autophagosomal
precursor structures, and inhibits autophagy [8, 24, 26,
27]. The UVRAG-containing class III PI3K complex also
regulates autophagy but it appears to act at the intersection
between autophagy and the endosomal transport pathways.
UVRAG initially associates with the BAR-domain protein
Bif-1, which may regulate mAtg9 traﬃcking from the trans-
Golgi network (TGN) [28, 29]. UVRAG then interacts
with the class C Vps/HOPS protein complex, promoting
the fusion of autophagosomes with late endosomes and/or
lysosomes [30]. Finally, the UVRAG-containing class III
protein complex binds to Rubicon, a late endosomal and
lysosomal protein that suppresses autophagosome matura-
tion by reducing hVps34 activity [26, 31]. Importantly, both
the Atg14L- and UVRAG-containing complexes interact
through Beclin 1 with Ambra1, which in turn tethers these
protein complexes to the cytoskeleton via an interaction with
dynein[32,33].Followingtheinductionofautophagy,ULK1
phosphorylates Ambra1 thus releasing the class III PI3K
complexes from dynein and their subsequent relocalization
triggers autophagosome formation. Therefore, Ambra1 con-
stitutes a direct regulatory link between the Atg1/ULK1 and
the PI3K complexes [32].
Together with the Atg1/ULK and the PI3K complexes,
Atg9is one ofthe ﬁrstfactorslocalizing tothepreautophago-
somal structure or phagophore assembly site (PAS), the
structure believed to be the precursor of the phagophore
[9,34](Figure 1).Atg9istheonlyconservedtransmembrane
protein that is essential for autophagy. It is distributed to
the PAS and multiple additional cytoplasmic tubulovesicular
compartments derived from the Golgi [35–37]. Atg9 cycles
between these two locations and consequently it is thought
to serve as a membrane carrier providing the lipid building
blocks for the expanding phagophore [37]. One of the
established functions of Atg9 is that it leads to the formation
of the yeast PAS when at least one of the cytoplasmic
tubulovesicular compartments translocates near the vacuole
[34]. Atg9 is also essential to recruit the PI3K Complex I
to the PAS [9]. Retrieval transport of yeast Atg9 from the
PAS and/or complete autophagosome is mediated by the4 International Journal of Cell Biology
Atg2-Atg18 complex [38] and appears to be regulated by
the Atg1/ULK and PI3K complexes [37]. Mammalian Atg9
(mAtg9) has similar characteristics to its yeast counterpart.
mAtg9 localizes to the TGN and late endosomes and redis-
tributes to autophagosomal structures upon the induction
of autophagy (Figure 1)[ 39], further promoting pathway
activity [29, 40–42]. As in yeast, cycling of mAtg9 between
locations also requires the Atg1/ULK complex and kinase
activity hVps34 [39, 43].
The core Atg machinery also entails two ubiquitin-like
proteins, Atg12 and Atg8/microtubule-associated protein 1
(MAP1)-light chain 3 (LC3), and their respective, partially
overlapping, conjugation systems [44–46]( Figure 1). Atg12
is conjugated to Atg5 through the activity of the Atg7 (E1-
like) and the Atg10 (E2-like) enzymes. The Atg12–Atg5
conjugate then interacts with Atg16, which oligomerizes to
formalargemultimericcomplex.Atg8/LC3iscleavedatitsC
terminus by the Atg4protease togeneratethe cytosolic LC3-I
with a C-terminal glycine residue, which is then conjugated
tophosphatidylethanolamine (PE)inareactionthatrequires
Atg7 and the E2-like enzyme Atg3. This lipidated form of
LC3 (LC3-II) is attached to both faces of the phagophore
membrane. Once the autophagosome is completed, Atg4
removes LC3-II from the outer autophagosome surface.
These two ubiquitination-like systems appear to be closely
interconnected. On one hand, the multimeric Atg12-Atg5-
Atg16 complex localizes to the phagophore and acts as an
E3-like enzyme, determining the site of Atg8/LC3 lipidation
[47, 48]. On the other hand, the Atg8/LC3 conjugation
machinery seems to be essential for the optimal functioning
of the Atg12 conjugation system. In Atg3-deﬁcient mice,
Atg12-Atg5 conjugation is markedly reduced, and normal
dissociation of the Atg12-Atg5-Atg16 complex from the
phagophore is delayed [49]. Some evidences suggest that
these two conjugation systems also function together during
the expansion and closure of the phagophore. For example,
overexpression of an inactive mutant of Atg4 inhibits the
lipidation of LC3 and leads to the accumulation of a
number of nearly complete autophagosomes [47]. While
controversial [50], it has been postulated that Atg8/LC3 also
possesses fusogenic properties, thus mediating the assembly
of the autophagic membrane [51, 52].
It has to be noted that mammals possess at least 7
genes coding for LC3/Atg8 proteins that can be grouped
into three subfamilies: (1) the LC3 subfamily containing
LC3A, LC3B, LC3B2 and LC3C; (2) the gammaaminobu-
tyrate receptor-associated protein (GABARAP) subfamily
comprising GABARAP and GABARAPL1 (also called GEC-
1); (3) the Golgi-associated ATPase enhancer of 16kDa
(GATE-16) protein (also called GABARAP-L2/GEF2) [53].
Although in vivo studies show that they are all conjugated
to PE, they appear to have evolved complex nonredundant
functions [54].
2.2. The Autophagosomal Membranes. The origin of the
membranes composing autophagosomes is a long-standing
mystery in the ﬁeld of autophagy. A major diﬃculty in
addressing this question has been that phagophores as well
as autophagosomes do not contain marker proteins of other
subcellular compartments [55, 56]. A series of new studies
has implicated several cellular organelles as the possible
source for the autophagosomal lipid bilayers. The plasma
membrane and elements of the traﬃcking machinery to
the cell surface have been linked to the formation of an
earlyautophagosomalintermediate,perhapsthephagophore
[57–61]. It is possible that early endosomal- and/or Golgi-
derived membranes are also key factors in the initial steps of
autophagy [34, 36, 39]. The Golgi, moreover, appears also
important for autophagy by supplying at least in part the
extra lipids required for the phagophore expansion [29, 62–
65]. The endoplasmic reticulum (ER) is also central in this
latter event. While the relevance of the ER in autophagosome
biogenesis was already pointed out a long time ago [5,
55, 66, 67], recently two electron tomography studies have
demonstrated the existence of a physical connection between
the ER and the forming autophagosomes [68, 69]. These
analyses have revealed that the ER is connected to the outer
as well as the inner membrane of the phagophore through
points of contact, supporting the notion that lipids could be
supplied via direct transfer at the sites of membrane contact.
In line with this view, it has been found that Atg14L is
associated to the ER and PI3P is generated on speciﬁc subdo-
mains of this organelle from where autophagosomes emerge
under autophagy-inducing conditions [25, 70]( Figure 1).
It has also been proposed that the outer membrane of the
mitochondria is the main source of the autophagosomal
lipid bilayers, but while the experimental evidences appear
to show that mitochondria are essential for the phagophore
expansion, it remains unclear whether these organelles play a
key role in the phagophore biogenesis [71]. The discrepancy
between the conclusions of the various studies has not
allowed yet drawing a model about the membrane dynamics
during autophagosome biogenesis. The diﬀerent results
could be due to the diﬀerent experimental conditions and
modelsystemsusedbythevariouslaboratories.Alternatively,
the lipids forming the autophagosomes could have diﬀerent
sources depending on the cell and the conditions inducing
autophagy [72, 73]. A third possibility is that the source of
phagophore membrane could depend on the nature of the
double-membrane vesicle cargo. Additional investigations
are required to shed light on these issues.
2.3.PharmacologicalManipulationofAutophagy. Despitethe
potential of curing, quite a substantial range of speciﬁc
pathological conditions by inducting autophagy, there are
currently no small molecules that allow to exclusively
stimulate this pathway [74]. Nevertheless, there is a variety
of chemicals that by acting on signaling cascades that also
regulateautophagypermittotriggerthisdegradativeprocess.
These agents fall into two distinct categories based on the
mechanism of action; whetherthey workthroughanmTOR-
dependent (Rapamycin or Torin) or mTOR-independent
pathway (e.g., lithium or resveratrol) [74]. In addition to
these compounds, there are biological molecules such as
interferon γ (IFNγ) and vitamin D that can be used to
stimulate autophagy especially in experimental setups [75,
76].International Journal of Cell Biology 5
Inhibition of autophagy can also be beneﬁcial in speciﬁc
diseases but as for the inducers there are no compounds
that exclusively block this pathway without aﬀecting other
cellular processes. The small molecules inhibiting autophagy
include wortmannin and 3-methyladenine, which hamper
the activity of the PI3K; Baﬁlomycin A and chloroquine,
which impair the degradative activity of lysosomes [77].
They are currently solely used in the basic research on
autophagy.
3. SelectiveTypesof Autophagy
3.1. The Molecular Machinery of Selective Autophagy. It is
becoming increasingly evident that autophagy is a highly
selective quality control mechanism whose basal levels are
important to maintain cellular homeostasis (see below). A
number of organelles have been found to be selectively
turned over by autophagy and cargo-speciﬁc names have
been given to distinguish the various selective pathways,
including the ER (reticulophagy or ERphagy), peroxisomes
(pexophagy), mitochondria (mitophagy), lipid droplets
(lipophagy), secretory granules (zymophagy), and even
parts of the nucleus (nucleophagy). Moreover, pathogens
(xenophagy), ribosomes (ribophagy), and aggregate-prone
proteins (aggrephagy) are speciﬁcally targeted for degrada-
tion by autophagy [78].
Selective types of autophagy perform a cellular qual-
ity control function and therefore they must be able to
distinguish their substrates, such as protein aggregates or
dysfunctional mitochondria, from their functional counter-
parts. The molecular mechanisms underlying cargo selection
and regulation of selective types of autophagy are still largely
unknown. This has been an area of intense research during
the last years and our understanding of the various selective
types of autophagy is starting to unravel. A recent genome-
wide small interfering RNA screen aimed at identifying
mammalian genes required for selective autophagy found
141 candidate genes to be required for viral autophagy and
96 of those genes were also required for Parkin-mediated
mitophagy [79].
In general, these pathways appear to rely upon speciﬁc
cargo-recognizing autophagy receptors, which connect the
cargo to the autophagic membranes. The autophagy recep-
tors might also interact with speciﬁcity adaptors, which
functionasscaﬀoldingproteinsthatbringthecargo-receptor
complex in contact with the core Atg machinery to allow
the speciﬁc sequestration of the substrate. The selective
types of autophagy appear to rely on the same molecular
core machinery as non-selective (starvation-induced) bulk
autophagy. In contrast, the autophagy receptors and speci-
ﬁcity adapters do not seem to be required for nonselective
autophagy.
Autophagy receptors are deﬁned as proteins being able
to interact directly with both the autophagosome cargo and
the Atg8/LC3 family members through a speciﬁc (WxxL)
sequence [80], commonly referred to as the LC3-interacting
region (LIR) motif [81] or the LC3 recognition sequences
(LRS) [82]. Based on comparison of LIR domains from
more than 20 autophagy receptors it was found that the LIR
consensus motif is an eight amino acids long sequence that
can be written D/E-D/E-D/E-W/F/Y-X-X-L/I/V. Although
not an absolute requirement, usually there is at least one
acidic residue upstream of the W-site. The terminal L-site is
occupiedbyahydrophobicresidue,eitherL,I,orV[83].The
LIR motifs of several autophagy receptors have been found
to interact both with LC3 and GABARAP family members
in vitro, but whether this reﬂects a physiological interaction
remains to be clariﬁed in most cases. It should be pointed
out that not all LIR-containing proteins are autophagy
cargo receptors. Some LIR-containing proteins, like Atg3
and Atg4B, are recruited to autophagic membranes to per-
form their function in autophagosome formation [84, 85],
whereas others like FYVE and coiled-coil domain-containing
protein 1 (FYCO1) interact with LC3 to facilitate autophago-
some transport and maturation [86]. Others might use an
LIR motif to become degraded, like Dishevelled, an adaptor
protein in the Wnt signalling pathway [87]. The adaptor
proteins are less well-described, but seem to interact with
autophagy receptors and work as scaﬀold proteins recruiting
and assembling the Atg machinery required to generate
autophagosomes around the cargo targeted to degradation.
Examples of autophagy adaptors are Atg11 and ALFY [88,
89].
Thelistofspeciﬁcautophagyreceptorsisrapidlygrowing
and the role of several of them in diﬀerent types of selective
autophagy will be described in detail in the reviews of this
special issue. Here we will brieﬂy discuss the best studied
form of selective autophagy, the yeast cytosol to vacuole
targeting (Cvt) pathway, as well as the best studied mam-
malian autophagy receptor, p62/sequestosome 1 (SQSTM1)
(Figure 2).
The Cvt pathway is a biosynthetic process mediating the
transport of the three vacuolar hydrolases, aminopeptidase
1 (Ape1), aminopeptidase 4 (Ape4) and α-mannosidase
(Ams1), and the Ty1 transposome into the vacuole [90,
91]. Ape1 is synthesized as a cytosolic precursor (prApe1),
which multimerizes into the higher order Ape1 oligomer,
to which Ape4, Ams1, and Ty1 associate to form the so-
called Cvt complex, prior to being sequestered into a small
autophagosome-like Cvt vesicle. Sequestration of the Cvt
complex into Cvt vesicles is a multistep process, which
requires the autophagy receptor Atg19, which facilitates
binding to Atg8 at the PAS, as well as the adaptor protein
Atg11 (Figure 2(a)) [92] .A t g 1 1a c t sa sas c a ﬀold protein by
directing the Cvt complex and Atg9 reservoirs translocation
to the PAS in an actin-dependent way and then recruiting
the Atg1/ULK complex [40, 93]. The PI3P-binding proteins
Atg20, Atg21, and Atg24 are also required for the Cvt
pathway [94, 95], but their precise function remains to be
elucidated. Interestingly, Atg11 overexpression was found to
recruit more Atg8 and Atg9 to the PAS resulting in more
Cvt vesicles. This observation indicates that Atg11 levels
could regulate the rate of selective autophagy, and maybe
also the size of the cargo-containing autophagosomes in
yeast [90, 96]. Indeed, a series of studies has revealed that
Atg11 is also involved in other types of selective autophagy
such as mitophagy and pexophagy. However, the autophagy
receptors involved in the diﬀerent Atg11-dependent types6 International Journal of Cell Biology
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Figure 2: Representative selective autophagy. (a) The cytoplasm-to-vacuole targeting (Cvt) pathway. Ape1 is synthesized as a cytoplasmic
precursor protein with a propeptide and rapidly oligomerizes into dodecamers that subsequently associate with each other to form a higher
order complex. The autophagy receptor Atg19 directly binds to the complex and mediates the recruitment of another Cvt pathway cargo,
Ams1, leading to the formation of the so-called Cvt complex. Atg19 also interacts with the autophagy adaptor Atg11 and this protein allows
the transport of the Cvt complex to the site where the double-membrane vesicle will be generated. At this location, Atg11 tethers the Atg
proteinsessentialfortheCvtvesicleformationandthedirectbindingof Atg19toAtg8permitstheexclusivesequestrationoftheCvtcomplex
into the vesicle. (b) A model for p62 and NBR1 as autophagy receptors for ubiquitinated cargos. p62 and NBR1 bind with ubiquitinated
cargos via their ubiquitin-associated (UBA) domain and this interaction triggers the aggregate formation through the oligomerization of
p62 via its Phox and Bem1p (PB1) domain. Furthermore, p62 interacts with both autophagy-linked FYVE protein (ALFY), which serves to
recruit Atg5 and to bind PI3P, and directly with LC3. This latter event appears to organize and activate the Atg machinery in close proximity
of the ubiquitinated cargos, which allows to selectively sequester them in the autophagosomes in analogous to the Cvt pathway.
of selective autophagy are diﬀerent as Atg32 is required for
mitophagy [97, 98], whereas Atg30 is essential for pexophagy
[99]. Like Atg19, these two proteins have an Atg8-binding
LIR motif and directly interact with Atg11. Mammalian cells
appear to not possess an Atg11 homologue, and further
studies are necessary to delineate the molecular machinery
involved in sequestration and targeting of diﬀerent cargoes
for degradation by autophagy in higher eukaryotes.
The mechanism of the Cvt pathway is reminiscent of the
selective form of mammalian autophagy called aggrephagy,
which involves degradation of misfolded and unwanted
proteins by packing them into ubiquitinated aggregates. In
both cases aggregation of the substrate (prApe1 or misfolded
proteins) is required prior to sequestration into Cvt vesicles
or autophagosomes, respectively [100–102]. Similar to Cvt
vesicles, aggregate-containing autophagosomes appear to be
largely devoid of cytosolic components suggesting that the
vesicle membrane expands tightly around its cargo [88].
Aggrephagy also depends on proteins with exclusive func-
tions in substrate selection and targeting [81, 88, 100, 103].
The autophagy receptors p62 and neighbour of BRCA1 gene
(NBR1) bind both ubiquitinated protein aggregates through
an ubiquitin-associated (UBA) domain and to LC3 via their
LIR motifs and, thereby, promote the speciﬁc autophagic
degradation of ubiquitinated proteins (Figure 2(b)) [81,
82, 100, 103, 104]. NBR1 and p62 also contain an N-
terminal Phox and Bem1p (PB1) domain through which
they can oligomerize, or interact with other PB1-containing
binding partners [83]. In addition to being a cargo recep-
tor for protein aggregates, p62 has been implicated in
autophagic degradation of other ubiquitinated substrates
such as intracellular bacteria [105], viral capsid proteins
[106], the midbody remnant formed after cytokinesis [107],
peroxisomes [108, 109], damaged mitochondria [110, 111],
and bacteriocidal precursor proteins [112]. The PB1 domain
was recently found to be required for p62 to localize to
the autophagosome formation site adjacent to the ER [113],
suggesting that it could target ubiquitinated cargo to the site
of autophagosome formation or alternatively promote the
assembly of the Atg machinery at this location.International Journal of Cell Biology 7
The large scaﬀolding protein autophagy-linked FYVE
(ALFY) appears to have a similar function as the speciﬁcity
adaptorAtg11.ALFYisrecruitedtoaggregate-proneproteins
through its interaction with p62 [101] and through a direct
interaction with Atg5 and PI3P it serves to recruit the
core Atg machinery and allow formation of autophagic
membranes around the protein aggregate [88]( Figure 2(b)).
Interestingly, ALFY is recruited from the nucleus to cytoplas-
mic ubiquitin-positive structures upon cell stress suggesting
that it might regulate the level of aggrephagy [114]. In line
with this, it was found that overexpression of ALFY in mouse
and ﬂy models of Huntington’s disease reduced the number
of protein inclusions [88]. It will be interesting to determine
whether ALFY, as p62, is involved in other selective types
of autophagy such as the one eliminating midbody ring
structures or mitochondria.
3.2. Regulation of Selective Autophagy. It is well known
that posttranslational modiﬁcations like phosphorylation
and ubiquitination are involved in the regulation of the
activity of proteins involved in autophagy and degradation
of autophagic cargo proteins, respectively. However, little
is known about how these modiﬁcations may regulate
selective autophagy. The fact that the core Atg machinery
is required for both nonselective and selective types of
autophagy gives raise to the question of whether these two
types of autophagy may compete for the same molecular
machinery. Such a competition could be detrimental for the
cells undergoing starvation and to avoid this, there might
be a tight regulation of the expression level and/or activity
of the proteins speciﬁcally involved the selective autophagy.
It has recently been proposed that phosphorylation of
autophagy receptors might be a general mechanism for the
regulation of selective autophagy. Dikic and coworkers noted
that several autophagy receptors contain conserved serine
residues adjacent to their LIR motifs and indeed, the TANK
bindingkinase1(TBK1)wasfoundtophosphorylateaserine
residue close to the LIR motif of the autophagy receptor
optineurin. This modiﬁcation enhances the LC3 binding
aﬃnity of optineurin and promotes selective autophagy
of ubiquitinated cytosolic Salmonella enterica [115]. In
yeast, phosphorylation of Atg32, the autophagy receptor for
mitophagy, by mitogen-activated protein kinases was found
to be required for mitophagy [116, 117].
The Atg8/LC3 proteins themselves have also been found
to become phosphorylated and recent works have iden-
tiﬁed speciﬁc phosphorylation sites for protein kinase A
(PKA) [118] and protein kinase C (PKC) [119] in the N-
terminal region of LC3. Interestingly, the N-terminal of
LC3 is involved in the binding of LC3 to LIR-containing
proteins [120]. It is therefore tempting to speculate that
phosphorylation of the PKA and PKC sites might facilitate or
prevent the interaction of LC3 with LIR-containing proteins
such as p62. It has been found that phosphorylation of
the PKA site, which is conserved in all mammalian LC3
isoforms, but not in GABARAP, inhibits recruitment of LC3
into autophagosomes [118].
The role of ubiquitin in autophagy has so far been
ascribed as a signal for cargo degradation. Ubiquitination
of aggregate prone proteins, as well as bacteria and mito-
chondria, has been found to serve as a signal for recognition
by autophagy receptors like p62 and NBR1, which are
themselves also degraded together with the cargo that they
associate with [83]. The in vivo speciﬁcity of p62 and
NBR1 toward ubiquitin signals remains to be established
under the diﬀerent physiological conditions. Interestingly, it
was recently found that casein kinase 2- (CK2-) mediated
phosphorylation of the p62 UBA domain increases the
bindingaﬃnityofthismotifforpolyubiquitinchainsleading
to more eﬃcient targeting of polyubiquitinated proteins
to autophagy [121]. CK2 overexpression or phosphatase
inhibition reduced the formation of aggregates containing
the polyglutamine-expanded huntingtin exon1 fragments
in a p62-dependent manner. The E3 ligases involved in
ubiquitination of diﬀerent autophagic cargo largely remains
to be identiﬁed. However, it is known that the E3 ligases
Parkin and RNF185 both regulate mitophagy [122, 123].
SMURF1 (SMAD-speciﬁc E3 ubiquitin protein ligase 1)
was recently also implicated in mitophagy, as well as in
autophagic targeting of viral particles [79]. Interestingly,
the role of SMURF1 in selective autophagy seems to be
independent of its E3 ligase activity, but it rather depends
on its membrane-targeting C2 domain, although the exact
mechanism involved remains to be elucidated. It is also
not clear whether ubiquitination could serve as a signal
to regulate the activity or binding selectivity of proteins
directly involved in autophagy, and whether this in some way
could regulate selective autophagy. The role of ubiquitin-
like proteins as SUMO and Nedd in autophagy is also
unexplored.
Acetylation is another posttranslational modiﬁcation
that only recently has been implicated in selective autophagy.
The histone de-acetylase 6 (HDAC6), initially found to
mediate transport of misfolded proteins to the aggresome
[124], was lately implicated in maturation of ubiquitin-
positive autophagosomes [125]. The fact that HDAC6 over-
production in ﬂy eyes expressing expanded polyQ proteins is
neuroprotective further indicates that HDAC6 activity stim-
ulates aggrephagy [126]. Furthermore, the acetylation of an
aggrephagy cargo protein, muntant huntingtin, the protein
causing Huntington’s disease, is important for its degrada-
tion by autophagy [127]. HDAC6 has been also implicated in
Parkin-mediated clearance of damaged mitochondria [128].
The acetyl transferase(s) involved in these forms of selective
autophagy is currently unknown, but understanding the role
of acetylation in relation to various aspects of autophagy
is an emerging ﬁeld and it will very likely provide more
mechanistic insights into these pathways.
4.Pathophysiological Relevance of
SelectiveTypesof Autophagy
Basal autophagy acts as the quality control pathway for
cytoplasmic components and it is crucial to maintain the
homeostasis of various postmitotic cells [129]. While this
quality control could be partially achieved by nonselective
autophagy, growing lines of evidence have demonstrated8 International Journal of Cell Biology
that speciﬁc proteins, organelles, and invading bacteria are
speciﬁcally degraded by autophagy (Figure 3).
4.1. Tissue Homeostasis. Mice deﬁcient in autophagy die
either in utero (e.g., Beclin 1 and Fip200 knockout mice)
[130–132] or within 24 hours after birth due, at least in
part, to a deﬁciency in the mobilization of amino acids
from various tissues (e.g., Atg3, Atg5, Atg7, Atg9, and Atg16L
knockout mice) [49, 133–136]. As a result, to investigate
the physiological roles of autophagy, conditional knockout
mice for Atg5, Atg7, or FIP200 and various tissue-speciﬁc Atg
knockoutmicehavebeenestablishedandanalyzed[133,137,
138]. For example, the liver-speciﬁc Atg7-deﬁcient mouse
displayed severe hepatomegaly accompanied by hepatocyte
hypertrophy, resulting in severe liver injuries [133]. Mice
lacking Atg5, Atg7, or FIP200 in the central nervous system
exhibitedbehavioraldeﬁcits,suchasabnormallimb-clasping
reﬂexes and reduction of coordinated movement as well
as massive neuronal loss in the cerebral and cerebellar
cortices [137–139]. Loss of Atg5 in cardiac muscle caused
cardiac hypertrophy, left ventricular dilatation, and sys-
tolic dysfunction [140]. Skeletal muscle-speciﬁc Atg5 or
Atg7 knockout mice showed age-dependent muscle atrophy
[141, 142]. Pancreatic β cell-speciﬁc Atg7 knockout animals
exhibited degeneration of islets and impaired glucose toler-
ance with reduced insulin secretion [143, 144]. Podocyte-
speciﬁc deletion of Atg5 caused glomerulosclerosis in aging
mice and these animals displayed increased susceptibility
to proteinuric diseases caused by puromycin aminonucle-
oside and adriamycin [145]. Proximal tubule-speciﬁc Atg5
knockout mice were susceptible to ischemia-reperfusion
injury [146]. Finally, deletion of Atg7 in bronchial epithelial
cells resulted in hyperresponsiveness to cholinergic stim-
uli [147]. All together, these results undoubtedly indicate
that basal autophagy prevents numerous life-threatening
diseases.
How does impairment of autophagy lead to diseases?
Ultrastructural analyses of the mutant mice revealed a
marked accumulation of swollen and deformed mitochon-
dria in the mutant hepatocytes [133], pancreatic β cells
[143, 144], cardiac and skeletal myocytes [140, 141]a n d
neurons [138], but also the appearance of concentric
membranous structures consisting of ER or sarcoplasmic
reticulum in hepatocytes [133], neuronal axons [137, 139]
and skeletal myocytes [141], as well as an increased number
of peroxisomes and lipid droplets in hepatocytes [133, 148].
In addition to the accumulation of aberrant organelles,
histological analyses of tissues with defective autophagy
showed the amassment of polyubiquitylated proteins in
almost all tissues (although the level varied from one region
toanother)forminginclusionbodieswhosesizeandnumber
increased with aging [149]. Consequently, basal autophagy
also acts as the quality control machinery for cytoplasmic
organelles (Figure 3(a)). Although this could be partially
achieved by bulk autophagy, these observations point to the
existence of selective types of autophagy, a notion that is now
supported by experimental data.
4.2.ImplicationsofSelectiveDegradationofp62byAutophagy.
p62/SQSTM1 is the best-characterized disease-related auto-
phagy receptor and a ubiquitously expressed cellular protein
conserved among metazoan but not in plants and fungi [83].
Besides a role of p62 as the receptor, this protein itself is
speciﬁc substrate for autophagy. Suppression of autophagy
is usually accompanied by an accumulation of p62 mostly
in large aggregates also positive for ubiquitin (Figure 3(a))
[104, 150]. Ubiquitin and p62-positive inclusion bodies have
been detected in numerous neurodegenerative diseases (i.e.,
Alzheimer’s disease, Parkinson’s disease, and amyotrophic
lateral sclerosis), liver disorders (i.e., alcoholic hepatitis and
steatohepatitis), and cancers (i.e., malignant glioma and
hepatocellular carcinoma) [151]. Very interestingly, the p62-
positive aggregates observed in hepatocytes and neurons of
liver- and brain-speciﬁc Atg7 deﬁcient mice, respectively,
as well as in human hepatocellular carcinoma cells, are
completely dispersed by the additional loss of p62 strongly
implicating involvement of p62 in the formation of disease-
related inclusion bodies [104, 152].
Through its self-oligomerization, p62 is involved in sev-
eral signal transduction pathways. For example, this protein
functionsasasignalinghubthatmaydeterminewhethercells
survive by activating the TRAF6–NF-κB pathway, or die by
facilitating the aggregation of caspase 8 and the downstream
eﬀectorcaspases[153,154]. Onthe otherhand, p62 interacts
with the Nrf2-binding site on Keap1, a component of
the Cullin 3-type ubiquitin ligase for Nrf2, resulting in
stabilization of Nrf2 and transcriptional activation of Nrf2
target genes including a battery of antioxidant proteins
[155–159]. It is thus plausible that excess accumulation or
mutation of p62 leads to hyperactivation of these signaling
pathways, resulting in a disease onset (Figure 3(b)).
Paget’s disease of bone is a chronic and metabolic bone
disorder that is characterized by an increased bone turnover
within discrete lesions throughout the skeleton. Mutations
in the p62 gene, in particular in its UBA domain, can cause
this illness [160]. A proposed model explaining how p62
mutations lead to the Paget’s disease of bone is the following:
mutations of the UBA domain cause an impairment in the
interaction between p62 and ubiquitinated TRAF6 and/or
CYLD, an enzyme deubiquitinating TRAF6, which in turn
enhances the activation of the NF-κB signaling pathway
and the resulting increased osteoclastogenesis (Figure 3(b))
[160]. If proven, this molecular scenario could open the
possibility of using autophagy enhancers as a therapy to cure
Paget’s disease of bone.
It is established that autophagy has a tumor-suppressor
role and several autophagy gene products including Beclin1
and UVRAG are known to function as tumor suppressor
proteins [161]. The tumor-suppressor role of autophagy
appears to be important particularly in the liver. Sponta-
neous tumorigenesis is observed in the livers of mice with
either a systemic mosaic deletion of Atg5 or a hepatocyte-
speciﬁc Atg7 deletion [152, 162]. Importantly, no tumors
are formed in other organs in Atg5 mosaically deleted mice.
Enlarged mitochondria, whose functions are at least partially
impaired, accumulate in Atg5- or Atg7-deﬁcient hepatocytes
[152, 162]. This observation is in line with the previousInternational Journal of Cell Biology 9
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Figure 3: Pathophysiological relevance of selective autophagy. (a, b) Selective types of autophagy operates constitutively at low levels even
under nutrient-rich conditions and mediates turnover of selected cytoplasmic materials through the action of autophagy receptors such as
p62 and NBR1. These proteins mediate the elimination of ubiquitinated structures, including protein aggregates (a) and defects in these
pathways lead to the disruption of tissue homeostasis, resulting in life-threatening diseases. Defective autophagy is usually accompanied by
extensive accumulation of p62-containing aggregates, which enhances its function as a scaﬀold protein in several signaling cascades such
as NF-κB signaling, apoptosis, and Nrf2 activation (b). Such abnormalities might be involved in tumorigenesis and Paget’s disease of bone.
(c) During erythroid diﬀerentiation, Nix/Bnip3L relocalization to mitochondria leads to their depolarization, which triggers mitophagy.
Loss of Nix/Bnip3L causes an arrest in the erythroid maturation arrest, leading to severe anaemia. In response to loss of the mitochondrial
membranepotential,ParkintranslocatesontothedamagedmitochondriainaPINK1-dependentmanner,andubiquitinatedproteinspresent
on the outer mitochondrial membrane, which induces mitophagy. Parkinson’s disease-related mutations in the Parkin and PINK1 genes
provoke a defect in mitophagy, suggesting this selective type of autophagy has a role in preventing the pathogenesis of the Parkinson’s
disease. (d) Speciﬁc bacteria invading the cytosol get ubiquitinated and are recognized by autophagy receptors such as p62, NDP52, and
optineurin (OPTN). This allows the speciﬁc sequestration of the microbes into autophagosomes and their delivery into the lysosomes for
degradation. (e) The lipid droplets are probably degraded by autophagy selectively. This selective type of autophagy, lipophagy, supplies
free-fatty acids utilized to generate energy through the β-oxidation. Impairments in lipophagy are known to cause accumulation of lipid
droplets in hepatocytes and reduced production of AgRP in neurons.10 International Journal of Cell Biology
data obtained in iBMK cell lines showing that both the
oxidative stress and genomic damage responses are activated
by loss of autophagy [163, 164]. Again, it is clear that
accumulation of p62, at least partially, contributes to tumor
growthbecausethesizeoftheAtg7−/− livertumorsisreduced
by the additional deletion of p62 [162], which may cause a
dysregulation of NF-κB signaling [165] and/or a persistent
activation of Nrf2 [166].
4.3. Selective Degradation of Ubiquitinated Proteins. Almost
all tissues with defective autophagy are usually displaying
an accumulation of polyubiquitinated proteins [149]. Loss
of autophagy is considered to lead to a delay in the
global turnover of cytoplasmic components [137] and/or
to an impaired degradation of substrates destined for the
proteasome [167]. Both observations could partially explain
theaccumulationofmisfoldedand/orunfoldedproteinsthat
is followed by the formation of inclusion bodies.
As discussed above, p62 and NBR1 act as autophagy
receptorsforubiquitinatedcargossuchasproteinaggregates,
mitochondria, midbody rings, bacteria, ribosomal proteins
andviruscapsids[83,168](Figure 3).Althoughthesestudies
suggest the role of p62 as an ubiquitin receptor, it remains
to be established whether soluble ubiquitinated proteins
are also degraded one-by-one by p62 and possibly NBR1.
A mass spectrometric analysis has clearly demonstrated
the accumulation of all detectable topologies of ubiquitin
chain in Atg deﬁcient livers and brains, indicating that
speciﬁc polyubiquitin chain linkage is not the decisive signal
for autophagic degradation [169]. Because the increase in
ubiquitin conjugates in the Atg7 deﬁcient liver and brain
is completely suppressed by additional knockout of either
p62 or Nrf2 [169], accumulation of ubiquitinated proteins
in tissues defective in autophagy might be attributed to p62-
mediated activation of Nrf2, resulting in global transcrip-
tional changes to ubiquitin-associated genes. Further studies
are needed to precisely elucidate the degradation mechanism
of soluble ubiquitinated proteins by autophagy.
4.4. Mitophagy. Concomitant with the energy production
through oxidative phosphorylation, mitochondria also gen-
erate reactive oxygen species (ROS), which cause damage
through the oxidation of proteins, lipids and DNA often
inducing cell death. Therefore, the quality control of mito-
chondria is essential to maintain cellular homeostasis and
this process appears to be achieved via autophagy.
It has been postulated that mitophagy contributes to
diﬀerentiation and development by participating to the
intracellular remodelling that occurs for example dur-
ing haematopoiesis and adipogenesis. In mammalian red
blood cells, the expulsion of the nucleus followed by the
removal of other organelles, such as mitochondria, are
necessary diﬀerentiation steps. Nix/Bnip3L, an autophagy
receptor whose structure resembles that of Atg32, is also
an outer mitochondrial membrane protein that interacts
with GABARAP [170, 171] and plays an important role
in mitophagy during erythroid diﬀerentiation [172, 173]
(Figure 3(c)). Although autophagosome formation probably
still occurs in Nix/Bnip3L deﬁcient reticulocytes, mitochon-
drial elimination is severely impaired. Consequently, mutant
reticulocytes are exposed to increased levels of ROS and
die, and Nix/Bnip3L knockout mice suﬀer severe anemia.
Depolarization of the mitochondrial membrane potential
of mutant reticulocytes by treatment with an uncoupling
agent results in restoration of mitophagy [172], emphasizing
the importance of Nix/Binp3L for the mitochondrial depo-
larization and implying that mitophagy targets uncoupled
mitochondria. Haematopoietic-speciﬁc Atg7 knockout mice
also exhibited severe anaemia as well as lymphopenia, and
the mutant erythrocytes markedly accumulated degenerated
mitochondria but not other organelles [174]. The mito-
chondrial content is regulated during the development of
the T cells as well; that is, the high mitochondrial content
in thymocytes is shifted to a low mitochondrial content
in mature T cells. Atg5 or Atg7 deleted T cells fail to
reduce their mitochondrial content resulting in increased
R O Sp r o d u c t i o na sw e l la sa ni m b a l a n c ei np r o -a n d
antiapoptotic protein expression [175–177]. All together,
these evidences demonstrate the essential role of mitophagy
in haematopoiesis.
Recent studies have described the molecular mechanism
by which damaged mitochondria are selectively targeted for
autophagy, and have suggested that the defect is implicated
in the familial Parkinson’s disease (PD) [178]( Figure 3(c)).
PINK1, a mitochondrial kinase, and Parkin, an E3 ubiquitin
ligase, have been genetically linked to both PD and a
pathway that prevents progressive mitochondrial damage
and dysfunction. When mitochondria are damaged and
depolarized, PINK1 becomes stabilized and recruits Parkin
to the damaged mitochondria [122, 179–181]. Various mito-
chondrial outer membrane proteins are ubiquitinated by
Parkin and mitophagy is then induced. Of note, PD-related
mutations in PINK1 and Parkin impair mitophagy [122,
179–181], suggesting that there is a link between defective
mitophagy and PD. How these ubiquitinated mitochondria
are recognized by the autophagosome remains unknown.
Although p62 has been implicated in the recognition of
ubiquitinated mitochondria, elimination of the mitochon-
dria occurs normally in p62-deﬁcient cells [182, 183].
4.5. Elimination of Invading Microbes. When speciﬁc bac-
teria invade host cells through endocytosis/phagocytosis,
a selective type of autophagy termed xenophagy, engulfs
them to restrict their growth [184]( Figure 3(d)). Although
neither the target proteins nor the E3 ligases have yet been
identiﬁed, invading bacteria such as Salmonella enterica,
Listeria monocytogenes, or Shigella ﬂexneri become positive
for ubiquitin when they access the cytosol by rupturing the
endosome/phagosome limiting membrane [185, 186]. These
ﬁndingsraisethepossibilitythatubiquitinalsoservesasatag
during xenophagy. In fact, to date, three proteins, p62 [105,
185, 187], NDP52 [188], and optineurin [115]h a v eb e e n
proposed to be autophagy receptors linking ubiquitinated
bacteria and LC3. An ubiquitin-independent mechanism
has recently been revealed; recognition of a Shigella mutant
that lacks the icsB gene requires the tectonin domain-
containing protein 1 (Tecpr1), which appears to be a newInternational Journal of Cell Biology 11
type of autophagy adaptor targeting Shigella to Atg5- and
WIPI-2-positive membranes [189]. Interestingly, the Shigella
icsB normally prevents autophagic sequestration of this
bacterium by inhibiting the interaction of Shigella VirG with
Atg5 indicating that some bacteria have developed mech-
anism to inhibit or subvert autophagy to their advantage
[190]. This latter category of pathogens also includes viruses
such as Herpes simplex virus-1 (HSV-1), which express an
inhibitor (ICP34.5) of Atg6/Beclin1 [106]. However, it was
recently shown that a mutant HSV-1 strain lacking ICP34.5
becomes degraded by selective autophagy in a SMURF1-
dependent manner [79], suggesting that selective autophagy
plays an important role in our immune system.
Recently, a diﬀerent antimicrobial function has been
assigned to autophagy and this function appears to be
selective. During infection, ribosomal protein precursors
are transported by autophagy in a p62-dependent manner
into lysosomes [112]. These ribosomal protein precursors
are subsequently processed by lysosomal protease into small
antimicrobial peptides. Importantly, it has been shown that
induction of autophagy during a Mycobacterium tuberculosis
infection leads to the fusion between phagosomes containing
this bacterium and autophagosomes, and the production
of the antimicrobial peptides in this compartment kills M.
tuberculosis [112].
4.6. Lipophagy. While the molecular mechanism is largely
unknown, autophagy contributes at least partially to the
supply of free fatty acids in response to fasting (Figure 3(e)).
Fasting provokes the increase of the levels of free fatty acids
circulating in the blood, which are mobilized from adipose
tissues. These free fatty acids are rapidly captured by various
organs including hepatocytes and then transformed into
triglycerides by esteriﬁcation within lipid droplets. These
lipid droplets appear to be turned over by a selective type
of autophagy that has been named lipophagy in order to
provide endogenous free fatty acids for energy production
through β-oxidation [148]. Indeed, liver-speciﬁc Atg7 deﬁ-
cient mice display massive accumulation of triglycerides
and cholesterol in the form of lipid droplets [191]. Agouti-
related peptide- (AgRP-) expressing neurons also respond to
increased circulating levels of free fatty acids after fasting and
then induce autophagy to degrade the lipid droplets [192].
Similar to the case in hepatocytes, autophagy in the neurons
supplies endogenous free fatty acids for energy production
and seems to be necessary for gene expression of AgPR,
which is a neuropeptide that increases appetite and decreases
metabolism and energy expenditure [192].
5. Conclusions andPerspectives
Originally, it was assumed that autophagy was exclusively a
bulk process. Recent experimental evidences have demon-
strated that through the use of autophagy receptors and
adaptors, this pathway can be selective by exclusively degrad-
ing speciﬁc cellular constituents. The list of physiological
and pathological situations where autophagy is selective
is constantly growing and this fact challenges the earliest
concept whether autophagy can be nonselective. It is believe
that under starvation, cytoplasmic structures are randomly
engulfedbyautophagosomesanddeliveredintothelysosome
to be degraded and thus generate an internal pool of
nutrients. In yeast Saccharomyces cerevisiae,h o w e v e r ,t h e
degradation of ribosomes, for example, ribophagy, as well
as mitophagy and pexophagy, and the transport of the
prApe1 oligomer into the vacuole under the same conditions
requires the presence of autophagy receptors [97, 193–195].
As a result, these observations suggest that autophagy could
potentially always operate selectively. This is a conceivable
hypothesis because this process allows the cell to survive
stress conditions and the casual elimination of cytoplasmic
structure in the same scenario could lead to the lethal
depletion of an organelle crucial for cell survival. Future
studies will certainly provide more molecular insights into
the regulation and mechanism of the selective types of
autophagy, and this information will also be important to
determine if indeed bulk autophagy exists.
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